UNSPSC 51282309: Azithromycin anhydrous

This classification denotes a macrolide antibiotic with the molecular formula C38H72N2O12, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J2KLZ20U1M, chemically known as 11-(4-dimethylamino-3-hydroxy-6-methyl-oxan-2-yl)oxy-2-ethyl-3,4,10-trihydroxy-13-(5-hydroxy-4-methoxy-4,6-dimethyl-oxan-2-yl)oxy-3,5,6,8,10,12,14-heptamethyl-1-oxa-6-azacyclopentadecan-15-one but more generally known as azithromycin, which bears US NIH Compound Identifier 55185. Azithromycin most often comes in base and hydrate forms.

UNSPSC 51282309 Azithromycin anhydrous is a Commodity code that, based on recent state and local procurement activity, encompasses broader pharmaceutical and medical supply procurement rather than azithromycin-specific acquisitions. State and local governments are soliciting generic pharmaceuticals, over-the-counter products, and emergency medical supplies under related codes and cooperative purchasing vehicles. The actual scope of work includes bulk purchases of generic multi-source pharmaceuticals, emergency response medical consumables (respiratory equipment, cardiac monitoring devices, endotracheal tubes, bandaging materials), and naloxone for community health initiatives. Issuing bodies span state health and human services departments, county health agencies, municipal fire departments, and cooperative purchasing alliances serving multiple jurisdictions. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration's Office of State Procurement, represents a significant vehicle for pharmaceutical procurement across participating states and local facilities.

Recent activity concentrates in Florida, Texas, and the Upper Midwest. The Texas Health and Human Services Commission issued RFI HHS0017013 in April 2026 to solicit vendor capabilities for a Therapeutic Pharmacy Initiative Direct-to-Manufacturer Prescriptions program, seeking information about direct contracting capacity and outcomes-based pricing models. The Minnesota MMCAP issued RFP S1070000015802 in January 2026 with a March 26, 2026 response deadline for generic multi-source pharmaceuticals and OTC products to be distributed across participating state and local government facilities in Minnesota and Oregon, with awards effective July 1, 2026. Seminole County, Florida released IFB 60459723LAS in June 2026 for annual procurement of 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems with quarterly deliveries, due July 26, 2023. The City of Tampa issued IFB 26P00145 in March 2026 for 169 line items of medical and first aid supplies for the Tampa Fire Department Rescue Division, with an estimated contract amount of $700,000.00 and a 5 percent bid discount sheltered for certified Small Local Business Enterprises (SLBEs).